A new study in JAMA led by Mass General Brigham researchers shows that AI can significantly speed up clinical trial ...

Some cancer survivors who have overcome the odds are facing another diagnosis: heart damage, from chemotherapy, radiation or ...

The apparent benefits at 2 years observed in the nonrandomized ALT-FLOW study pave the way for a sham-controlled trial.

To predict arrhythmic risk in carriers of filamin C truncating variants, a novel risk predictive model was developed based on ...

Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...

Berlin Heals Holding AG, a late stage MedTech start up, has developed a breakthrough method and a product for the therapy of ...

Atrial fibrillation (irregular heartbeat), which causes poor blood flow, is another cardiovascular condition that can cause ...

Less than 5% of hospitalized adults with type 2 diabetes received an SGLT2 inhibitor or GLP-1 before being discharged, ...

Minimally invasive heart procedures like transcatheter aortic valve replacement (TAVR) and MitraClip placement to treat mitral regurgitation can improve quality of life, and even be lifesaving, for ...

The deaths are also partly the result of medical successes: People are living longer, and more people are surviving heart ...

A novel AI-assisted patient screening tool significantly improved the speed of determining eligibility and enrollment in a ...

People with pockets of fat hidden inside their muscles are at a higher risk of dying or being hospitalised from a heart attack or heart failure, regardless of their body mass index, according to ...